Columbia University Medical Center - Herbert Irving Comprehensive Cancer Center HICCC is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Columbia University Medical Center - Herbert Irving Comprehensive Cancer Center HICCC has participated in 1 clinical trials.
Therapeutic areas: Systemic Mast Cell Activation, KIT D816V Mutation.
Sponsors: Blueprint Medicines Corporation.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Columbia University Medical Center - Herbert Irving Comprehensive Cancer Center HICCC has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Columbia University Medical Center - Herbert Irving Comprehensive Cancer Center HICCC has 1 clinical trials on record. Their work covers Systemic Mast Cell Activation, KIT D816V Mutation.
Columbia University Medical Center - Herbert Irving Comprehensive Cancer Center HICCC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.